Skip to main content

Idiopathic Hypersomnia Clinical Trials

Living With the Challenges of Idiopathic Hypersomnia?

Discover a New Path to Wellness Through Idiopathic Hypersomnia Clinical Trials

Idiopathic hypersomnia (IH) is a chronic neurological sleep disorder characterized by excessive daytime sleepiness (EDS) despite adequate or prolonged nighttime sleep. People with IH may experience severe sleep inertia (difficulty waking up), mental fog, reduced concentration, prolonged sleep duration, and persistent fatigue. These symptoms often interfere with work, school, and daily functioning, making idiopathic hypersomnia management an ongoing challenge for many patients.

Revive Research Institute is conducting IH clinical trials evaluating an investigational treatment option, which aims to reduce excessive sleepiness, improve wakefulness, and enhance overall quality of life for individuals living with idiopathic hypersomnia. These idiopathic hypersomnia clinical trials also support those seeking updated idiopathic hypersomnia treatment options through research.

To be eligible for idiopathic hypersomnia clinical trials, participants must:

  • Be 18 years of age or older.
  • Have a documented diagnosis of idiopathic hypersomnia (IH)

*Additional eligibility criteria may apply.

*Participation in idiopathic hypersomnia clinical trials may provide access to expert medical care, regular health monitoring, and investigational therapies at no cost. Health insurance is not required to take part in these studies, and joining an idiopathic hypersomnia research study may help advance future therapies.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.
Idiopathic Hypersomnia Clinical Trials

About the Idiopathic Hypersomnia Clinical Trial

Idiopathic hypersomnia causes excessive daytime sleepiness, difficulty waking up, cognitive issues, and overwhelming fatigue. Current treatment options may not provide adequate relief for many individuals, increasing interest in idiopathic hypersomnia clinical trials Michigan for those seeking new solutions.

Revive Research Institute is conducting a clinical study for idiopathic hypersomnia to evaluate an investigational treatment for idiopathic hypersomnia. This study aims to discover whether new therapies can help control symptoms associated with this condition while contributing to idiopathic hypersomnia management progress.

Participants who meet eligibility after the screening process and qualify for enrollment will receive study-related care, lab assessments, and the investigational medication at no cost.

*All study procedures, doctor visits, and study-related medications are provided free of charge. Insurance is not required, and participants may be compensated for time and travel.
*To take the next step, complete the form above, and a member of our clinical research team will contact you for a brief pre-screening. You’ll discuss your health history and learn if you qualify for the study.

Get Started: What to Expect?

If you qualify for the idiopathic hypersomnia clinical trial in Michigan, you may have access to promising potential treatment options designed to manage symptoms more effectively through investigational treatment for idiopathic hypersomnia.

After submitting your information, our research team will contact you for a short pre-screening call. If you meet initial requirements, you will be invited to our research site for a screening visit, where we will review your medical history, perform physical exams, and run lab tests.

Those who qualify will review and sign an informed consent form (ICF), explaining study procedures, potential risks, and benefits. Once enrolled, you will receive investigational treatment and ongoing care from our dedicated research staff.

Our team ensures every participant understands their role and feels supported throughout the study. By participating, you help advance treatment options that could benefit future patients through idiopathic hypersomnia research study efforts.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Age

18 years or older

Condition

Idiopathic Hypersomnia (IH)

Location

Michigan

Understanding Idiopathic Hypersomnia

Understanding Idiopathic Hypersomnia

Common Symptoms:

  • Excessive daytime sleepiness
  • Severe sleep inertia
  • Difficulty waking up
  • Long sleep duration
  • Mental fog / poor concentration
  • Persistent fatigue

Common Risk Factors:

  • Neurological dysfunction
  • Genetic predisposition
  • Unknown underlying cause (idiopathic)

IH currently has no cure, making research essential for improving symptom management and quality of life. Many individuals join idiopathic hypersomnia clinical trials to explore whether new therapies can support better daily functioning.

Frequently Asked Questions (FAQs)

What is idiopathic hypersomnia?

Idiopathic hypersomnia is a chronic neurological sleep disorder causing excessive daytime sleepiness, long sleep times, and severe difficulty waking up. The condition has no known cause.

Why is IH challenging to manage?

Symptoms such as persistent sleepiness and cognitive impairment can severely affect daily functioning, and current treatments may not work well for everyone, which is why idiopathic hypersomnia treatment options continue to evolve through research.

How is IH treated now?

Treatments often include medications, behavioral strategies, and sleep hygiene methods. However, these options may not fully relieve symptoms, prompting interest in investigational treatment for idiopathic hypersomnia.

Why should I participate in the trial?

By joining a clinical study for idiopathic hypersomnia, you can access investigational therapies at no cost, receive specialized care, and contribute to developing new idiopathic hypersomnia treatment options that may help improve outcomes for future patients.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com